Trial of TRC105 and Sorafenib in Patients With HCC

Clinical trial NCT02560779 · COMPLETED

Trial details

NCT number: NCT02560779
Sponsor: Tracon Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2016-11-01
Primary completion: 2019-08-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.